Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference

WESTLAKE VILLAGE, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) — Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and aesthetics company, today announced that Frederick C. Beddingfield III,…

About Globe Newswire

Nasdaq Globenewswire on NEWSTAGE
View all posts by Globe Newswire →

Leave a Reply

Your email address will not be published. Required fields are marked *